drugset
Drugs / SpiN-Tec MCTI UFMG
last change May 2025 re-read 3 minutes ago

SpiN-Tec MCTI UFMG

Protein / enzyme biologic

Developed for
COVID-19
Investigated by
Federal University of Minas Gerais · Oswaldo Cruz Foundation · Prefeitura de Belo Horizonte (PBH) · The Ministry of Science, Technology and Innovation, Brazil

Trials 1

today NCT07134725 · Ph 1/2
2023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/2 NCT07134725 Nov 2022 → May 2023 COVID-19 Federal University of Minas Gerais Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as SpiN-Tec MCTI UFMG ClinicalTrials.gov intervention name — accepted as the source's own label NCT07134725 ↗
Modality Protein / enzyme biologic “Chimeric recombinant protein (SpiN) adjuvanted with CTVad1” NCT07134725 ↗